Evidence map›Paper›PMID 36428644›Full record

ArticleCancers2022

CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [

Katarína Benčurová, Joachim Friske, Maximilian Anderla, Manuela Mayrhofer, Thomas Wanek, Lukas Nics, Gerda Egger, Thomas H Helbich, Marcus Hacker, Alexander Haug and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. In-ovo imaging using ostrich eggs: biodistribution of F-18-FDG in ostrich embryos.Experimental biology and medicine (Maywood, N.J.) · 2025
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Katarína BenčurováLudwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria.ORCID 0000-0001-6762-0528
Joachim FriskeDivision of Molecular and Structural Preclinical Imaging, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.
Maximilian AnderlaLudwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria.
Manuela MayrhoferSchool of Medical Engineering and Applied Social Sciences, University of Applied Sciences Upper Austria, 4020 Linz, Austria.
Thomas WanekDivision of Molecular and Structural Preclinical Imaging, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.
Lukas NicsDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.
Gerda EggerLudwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria.ORCID 0000-0003-2489-155X
Thomas H HelbichDivision of Molecular and Structural Preclinical Imaging, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-3169-778X
Marcus HackerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-4222-4083
Alexander HaugDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-8308-6174
Markus MitterhauserLudwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria.
Theresa BalberLudwig Boltzmann Institute Applied Diagnostics, 1090 Vienna, Austria.ORCID 0000-0002-8154-5680
Medical University of Vienna · ATLudwig Boltzmann Institute Applied Diagnostics · ATUniversity of Vienna · ATChristian Doppler Laboratory for Thermoelectricity · ATComprehensive Cancer Center Vienna · ATUniversity of Applied Sciences Upper Austria · AT

Funding

Austrian Research Promotion Agency 879117
6 · The paper itself

Abstract

Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. Increased expression of CXCR4 has been associated with liver metastasis, disease progression, and shortened survival. Using in vitro cell binding studies and the in ovo model, we aimed to investigate the potential of [

Indexed as

2-[18F]FDG[68Ga]Ga-PentixaforCAM-xenograftcolorectal cancerCRC imagingCXCR4HCT116HT29in ovoPET/MRI

Identifiers

PMID36428644
PMCPMC9688097
OpenAlexW4308970953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.